Literature DB >> 34149173

Cytotoxic activities of Hypericum perforatum L. extracts against 2D and 3D cancer cell models.

Ivana Z Matić1, Sercan Ergün2, Marija Đorđić Crnogorac1, Sema Misir3, Yüksel Aliyazicioğlu4, Ana Damjanović1, Hurija Džudžević-Čančar5, Tatjana Stanojković1, Kalbiye Konanç6, Nina Petrović1,7.   

Abstract

Six extracts were obtained from plant species Hypericum perforatum L., collected at Samsun in Turkey. The aim of this study was to examine the mechanisms of the anticancer activity of these extracts. Methanol, ethyl-acetate and hexane were used as a solvents for extraction from both branch-body part of the plant (extracts 1, 2 and 3) and from plant flowers (extracts 4, 5 and 6). The cytotoxic effects of the extracts were determined against 2D and 3D cancer cell models. Cell cycle changes of treated HeLa cells were analyzed by flow cytometry. Measurements of gene and microRNA expression levels in treated HeLa cells were done by quantitative real time PCR. Five examined extracts (2-6) exerted selective concentration-dependent cytotoxic effects on HeLa, K562, and A549 cancer cells, while the extract 1 exhibited very weak cytotoxicity. The extract 6 showed the highest intensity of cytotoxic activity. All tested extracts (2-6) demonstrated the ability to induce apoptosis in HeLa cells through activation of caspase-3. These extracts remarkably decreased gene expression levels of MMP2, MMP9, TIMP3, and VEGFA in HeLa cells. Flower extracts might have stronger effects on miR128/193a-5p/335 level changes than branch-body extracts. Hypericum perforatum extracts exerted weaker cytotoxic effects on 3D HeLa spheroids when compared with their effects on 2D monolayer HeLa cells. Taken together, results of our research may suggest the promising anticancer properties of the Hypericum perforatum extracts.
© The Author(s), under exclusive licence to Springer Nature B.V. 2021.

Entities:  

Keywords:  3D HeLa spheroids; Cytotoxic activity; Hypericum perforatum; Matrix-metalloproteinase; Vascular endothelial growth factor; miR128/193a-5p/335

Year:  2021        PMID: 34149173      PMCID: PMC8167025          DOI: 10.1007/s10616-021-00464-5

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.040


  34 in total

Review 1.  St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.

Authors:  J Barnes; L A Anderson; J D Phillipson
Journal:  J Pharm Pharmacol       Date:  2001-05       Impact factor: 3.765

2.  Taxonomy and Chemotaxonomy of the Genus Hypericum.

Authors:  Sara L Crockett; Norman K B Robson
Journal:  Med Aromat Plant Sci Biotechnol       Date:  2011-01

3.  Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging.

Authors:  Nele Evens; Caroline Vandeputte; Giulio G Muccioli; Didier M Lambert; Veerle Baekelandt; Alfons M Verbruggen; Zeger Debyser; Koen Van Laere; Guy M Bormans
Journal:  Bioorg Med Chem       Date:  2011-06-16       Impact factor: 3.641

4.  Identification of the major constituents of Hypericum perforatum by LC/SPE/NMR and/or LC/MS.

Authors:  Evangelos C Tatsis; Sjef Boeren; Vassiliki Exarchou; Anastassios N Troganis; Jacques Vervoort; Ioannis P Gerothanassis
Journal:  Phytochemistry       Date:  2006-12-29       Impact factor: 4.072

5.  Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Authors:  Da Yang; Yan Sun; Limei Hu; Hong Zheng; Ping Ji; Chad V Pecot; Yanrui Zhao; Sheila Reynolds; Hanyin Cheng; Rajesha Rupaimoole; David Cogdell; Matti Nykter; Russell Broaddus; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Jinsong Liu; Ilya Shmulevich; Anil K Sood; Kexin Chen; Wei Zhang
Journal:  Cancer Cell       Date:  2013-02-11       Impact factor: 31.743

6.  Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.

Authors:  Christoph M Schempp; Vladimir Kirkin; Birgit Simon-Haarhaus; Astrid Kersten; Judit Kiss; Christian C Termeer; Bernhard Gilb; Thomas Kaufmann; Christoph Borner; Jonathan P Sleeman; Jan C Simon
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

7.  In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.

Authors:  M W Roomi; J C Monterrey; T Kalinovsky; M Rath; A Niedzwiecki
Journal:  Oncol Rep       Date:  2010-03       Impact factor: 3.906

8.  Phytochemical profiles, phototoxic and antioxidant properties of eleven Hypericum species - A comparative study.

Authors:  Edoardo Napoli; Laura Siracusa; Giuseppe Ruberto; Alessandra Carrubba; Silvia Lazzara; Antonio Speciale; Francesco Cimino; Antonella Saija; Mariateresa Cristani
Journal:  Phytochemistry       Date:  2018-05-21       Impact factor: 4.072

9.  Downregulation of FoxM1 inhibits proliferation, invasion and angiogenesis of HeLa cells in vitro and in vivo.

Authors:  Hong Chen; Yang Zou; Hong Yang; Jingjing Wang; Hong Pan
Journal:  Int J Oncol       Date:  2014-09-09       Impact factor: 5.650

10.  In vitro antitumor actions of extracts from endemic plant Helichrysum zivojinii.

Authors:  Ivana Z Matić; Ivana Aljančić; Željko Žižak; Vlatka Vajs; Milka Jadranin; Slobodan Milosavljević; Zorica D Juranić
Journal:  BMC Complement Altern Med       Date:  2013-02-18       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.